ONC
NASD BeOne Medicines Ltd. Sponsored ADR$367.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $367.00, $1.05 below the day’s high of $368.05
- YTD change
- +20.80%
- vs 20-day SMA
- +2.93%
- vs 200-day SMA
- +15.05%
Price ranges
Price & Performance
+82.92 (+29.19%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 4.7% away from all-time highs of $385.22
- ONC is up 21% since the beginning of the year
- ONC is up 13% over the past 12 months
- ONC is down 1% over the past 1 month
- 1% of all ONC investors are betting against ONC
ONC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +10.3%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +4.61%
- vs 8-day SMA
- +2.23%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
